Australia is running a 12-month trial that changes how eligible women can access certain health services. The policy allows eligible women to consult a pharmacist for either UTI treatment or access to the pill, with no out-of-pocket consultation fee.

Both outlets describe the trial’s structure, but place emphasis differently. ABC Australia frames the change through a question of whether it is a “win for women,” focusing on access and potential benefits for patients. The Conversation highlights not only how access is changing, but also whether the approach is backed by evidence, pointing readers toward an evaluation of the policy’s rationale and support. With both sources aligning on the core details—pharmacist consultations, eligibility, and the removal of the consultation fee—the main difference lies in whether the coverage leads with impact on women’s access or with evidence for the policy’s effectiveness.